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Basic Investigations 
The Proteomic Research of the Cure of Experimental Diabetes Deafness 
by Granules of Eliminating Phlegm and Removing Blood Stasis  
GUO Hong 䛁ᅣ 1,2, and XIONG Da-jing ❞໻㒣 3 
Objective: Observing the expression changes of serum proteome in model rats after intervention of the Granules of 
Eliminating Phlegm and Removing Blood Stasis (䈕⯄⼯⯔乫㉦also known as GEPRB), screening out and 
identifying the differentially expressed proteins by mass spectrometry and bioinformatics analysis, discussing the 
molecular mechanism of control the Diabetes deafness by GEPRB. 
Methods: By use of proteomics technology, the serum protein serum proteome of the control group, model control 
group, Duxil and each observation group were observed for 2-DE gel pattern matching, and the difference in the 
relative content of 2 times was chosen for the differentially expressed proteins. Identification of differentially 
expressed proteins by MALDI-TOF MS/MS, the authors further analysis the phosphorylation, subcellular 
localization, interaction, direct regulation, and transmembrane of the differences proteins by the way of 
bioinformatics analysis. Sixty SPF level SD rats elected in diabetic rats model group (abbreviated as DM group) 
were be randomly divided into 5 groups based on random number sheet, namely model control group, positive drug 
control group (Du-ke-xi group) and Mai-tong-fang high, medium and low dose group respectively. In addition, set 
of normal control group. 10 rats in each group. 
Results: By Coomassie brilliant blue staining, identified 51 differential protein spots dug from 2-D gel by mass 
spectrometry, successfully identified 13 non-redundant proteins. Most of the identified proteins were secreted 
protein and belong to different protein families. There were about 12 proteins have the transmembrane region from 
the authors’ result, ten of them were plasma membrane proteins. 
Conclusion: It’s suggesting that 13 differential proteins is most likely the protein response to GEPRB in vivo, these 
proteins may play key role for the treatment of GEPRB to Diabetes deafness. The two highly differentially 
expressed proteins Apolipoprotein E (apoE) and C3 may be a potential drug target of GEPRB. 
Keywords: Granules of Eliminating Phlegm and Removing Blood Stasis, also known as GEPRB; Diabetes deafness, 
also known as DD; two-dimentional electrophoresis, also known as 2-DE; Matrix-assisted laser desorption 
ionization-time of flight- mass Spectrometry, also known as MS; Serum proteomics 
Diabetes is a group of metabolic diseases in which a 
person has high blood sugar. The incidence of diabetes 
increases gradually in recent years. The pathogenesis of 
diabetes is complex and is proved to be associated with 
disorders of multiple metabolic pathways, such as 
carbohydrates or lipids metabolism.1, 2  
Diabetes deafness (DD) is a frequent diabete related 
disease which caused disorders in patients hearing. The 
mechanism of this disease is poorly understood although 
there are many drugs curing this disease including TCM. 
Many other mechanism researches about this disease 
mainly focused on the gene transcriptional level.3 But the 
conductors of most biological functions are proteins, in 
order to understood this process, the proteome level is 
believed to be especially important. 
The authors used serum proteomic methods and 
bioinformatics to clarify the therapeutic mechanism of 
the Granules of Eliminating Phlegm and Removing 
Blood Stasis (䈕⯄⼯⯔乫㉦also known as GEPRB) in 
DD and provide possible potential targets for DD 
treatment for the first time. This GEPRB as an effective 
clinical treatment of diabetes deafness has been used for 
many years in China. Now it has been reported as 
follows. 
MATERIALS AND METHODS 
Granules of Eliminating Phlegm and Removing Blood 
Stasis (Herbal materials) and Preparation Method 
GEPRB was purchased from Chengdu Green Valley 
Drugs Manufacture Limited Company. The formula 
consisted of eleven herbal components: Huang QI (Radix 
Astragali), Bupleurum chinensis, Salvia miltiorrhiza, 
Chinese matrimony-vine, Safflower, Kudzu root, French 
pinellia, South gallbladder star, dried whole scorpion, 
Chinese honey locust thorn, Licorice. Gross weight 
25,300 g. Various medicines divide equally. Inquiry into 
powder, extraction agents. And then added excipients.1
Experimental Animals and Protein Sample 
Preparation 
Sixty SPF level SD rats male, 40 days age, weight 200
–220 g were purchased from the Experimental Animal 
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Center of Guangdong Province (License number: 
2009-0809). All animal experiments involved ethical and 
humane treatment under a license. All the rats were fed a 
standard diet and had normal auricle reflex. Rats were 
divided into 6 groups: normal control (also known as 
“cont” or “K”), disease model (also known as “Model” 
or “M”), control drug treated (Duxil, also known as
“X”), GEPRB treated with low dose (also known as 
“low” or “D”), GEPRB treated with middle dose (also 
known as “middle” or “Z”), GEPRB treated with high 
dose (also known as “high” or “G”). Each group 
contained 10 rats. 
Disease model was prepared as previously described.4 In 
brief, rats with normal blood glucose level were used for 
streptozotocin (STZ)-induced DD model. Rats were 
starved for at least 12 hours. Next, STZ was dissolved in 
0.1 mol/L sodium citrate buffer (pH 4.5) in a 
concentration of 10 g/L and was injected into rats at the 
dosage of 55 mg/kg for one time. After one week of 
injection, the blood glucose level was examined. Rats 
with blood glucose level over 16.7 mmol/L were 
considered to be successfully constructed. The normal 
control rats were injected with physiological saline. 
Rats were treated with different drugs with different 
dosages as followings: Duxil (8 mg/kg), GEPRB group 
with low dose (7.8 g/kg), GEPRB group with middle 
dose (15.6 g/kg) and GEPRB group with high dose (31.1 
g/kg). Drugs were filled once per day for 10 weeks. The 
normal control group and disease model group were 
treated with equivalent of physiological saline as control. 
After treatments, total serum protein was prepared as 
previously discribed.5 In brief, 4 mL of blood was 
prepared from left common carotid artery. Sodium citrate 
(3.2%) was used as gelation inhibitor. The samples were 
centrifuged for 10 min at 3,000 rpm, and the supernatants 
were collected and stored at -80 . Albumin and Igć G 
were removed before subjected to 2-DE according to the 
manufacturer’s instruction (http://www.sigmaaldrich. 
com/china-mainland.html). 
2-DE 
Purified serum samples were used for 2-DE. Protein 
concentrations were determined by Bradford. All 
samples were stored at -80  before electrophoresis.ć
2-DE was performed with Ettan DALT six System 
electrophoresis units using the protocol suggested by the 
manufacturer. Briefly, total proteins (500 μg) were mixed 
up to 250 μL with rehydration solution 8 mol/L urea, 2% 
CHAPS, 20 mmol/L DTT and 0.5% IPG buffer) and run 
in IEF using a 24 cm immobilized pH 4–7 nonlinear 
gradient IPG strips. The rehydration step was carried out 
for 6 hours at low voltage of 30 V. IEF was run following 
a step-wise voltage increase procedure: 30 V, 60 V, 200 V, 
500 V, 1000 V, 3500 V, 10000 V and 1000 V for 6 h, 6 h, 
1 h, 2 h, 2 h, 2.5 h, 1 h, 8 hour each with a total of 78,350 
VHr.  
After IEF, the strips were subjected to two-step 
equilibration in equilibration buffers (6 mol/L urea, 30% 
glycerol, 2% SDS and 50 mmol/L Tris-HCl pH 6.8) with 
1% DTT(w/v) for the first step, and 2.5% iodoacetamide 
(IAA, w/v) for the second step. The equilibrated gel 
strips were placed on top of a 12.5% SDS-PAGE gel and 
sealed with 0.5% agarose containing a little bromophenol 
blue. SDS-PAGE was performed for 50 min at a constant 
current of 2 W/gel and 12 W per gel and then 17 W/gel 
and 100 W per gel until the bromophenol blue reached 
the bottom of the gels. The amount of protein was 
detected by coomassie brilliant blue staining. 
Image Analysis 
Analytical gels were scanned on an Image Scanner at 
300 dpi with 256-bit gray scale levels in tagged image 
file format, and images were analyzed using the 
ImageMaster 2D Platinum (GE Healthcare). All gels in 
the analyses were scanned with identical parameters. The 
individual spots of each gel were detected by their 
boundaries, and the spot volumes corresponding to the 
protein abundance were calculated automatically. Each 
spot intensity volume was processed by background 
subtraction and total spot volume normalization. The 
resulting spot volume percentage was used for 
comparison. Manual editing of the gels was necessary 
especially in the higher molecular weight region. The 
abundance of spot (Vol %) was selected to comparing, 
the abundance different values of all the matching spots 
between the two class was reported, the spot with ratio 
greater than 2.0 was selected to list. Proteins were 
classified as being differentially expressed between the 
two types of samples. The normalized value for each 
protein spot volume was used for comparison. One-tailed 
Student’s t-test was used for statistically analyzing the 
data extracted from comparison window of ImageMaster 
software that displayed the normalized volumes for each 
protein spot. A value of P<0.05 was considered 
significant. Only those spots that had statistical 
significance in differential expression were excised from 
gels for analysis by MS.6,7
Tryptic in-gel Digestion and MALDI-TOF MS/MS 
Analysis 
Protein spots were excised and transferred into 
siliconized 0.5 mL Eppendorf tubes. Each gel piece was 
rinsed twice with deionized water, destained in a 1:1 
solution of 30 mmol/L potassium ferricyanide and 100 
mmol/L sodium thiosulfate and then equilibrated in 50 
mmol/L ammonium bicarbonate to pH 8.0. After 
hydrating with acetonitrile (ACN) and drying in a Speed 
Vac (Thermo Fisher Scientific, Waltham, MA, USA), the 
gel spots were rehydrated in a minimal volume of trypsin 
(Promega, USA) solution (20 mg/mL in 25 mmol/L 
NH4HCO3) and incubated at 37 ć overnight.The 
supernatants were transferred into a 200 μL micro- 
centrifuge tube and the gels were extracted once with 
extraction buffer (67% ACN containing 2.5% 
trifluoroacetic acid, TFA). The peptide extract and the 
supernatant of the gel spot were combined and then 
completely dried in a SpeedVac centrifuge. Protein 
digestion extracts (tryptic peptides) were resuspended 
with 5 μL of 0.1% TFA and then the peptide samples 
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were mixed (1:1 ratio) with a matrix consisting of a 
saturated solution of -cyano-4-hydroxy-trans-cinnamic 
acid (CHCA) in 50% ACN containing 0.1% TFA. 
Aliquots of 0.8 μL were spotted onto stainless steel 
sample target plates. 
Peptide mass spectra were obtained on an Ultraflex III 
MALDI-TOF MS/MS spectrometer (Ultraflex III, 
Bruker). Data was acquired in positive MS reflector 
using a CalMix5 standard to calibrate the instrument. For 
MS/MS spectra, the five most abundant precursor ions 
per sample were selected for subsequent fragmentation 
and 900–1200 laser shots were accumulated per 
precursor ion. The criterion for precursor selection was a 
minimum S/N of 50. Both the MS and MS/MS data were 
interpreted and processed by using the Biotools software, 
and then the obtained MS and MS/MS spectra per spot 
were combined and submitted to MASCOT search 
engine (Matrix Science, London, UK) and searched with 
the following parameters: NCBInr (Rat) database, trypsin 
of the digestion enzyme, one missed cleavage site, partial 
modification of cysteine carboamido methylated and 
methionine oxidized, none-fixed modifications, MS 
tolerance of 100 ppm, MS/MS tolerance of 0.7 Da. 
Known contaminant ions (keratin) were excluded. Total 
of 69, 012 sequences and 29, 002, 682 residues in the 
database were actually searched.  
Protein Categorization and Network Construction 
Differentially expressed proteins were classified based 
on the PANTHER (Protein Analysis through 
Evolutionary Relationships) system (http://www. 
pantherdb.org), which is a unique resource that classifies 
genes and proteins by their functions. In the process, the 
PANTHER ontology, a highly controlled vocabulary 
(ontology terms) by biological process, molecular 
function, and molecular pathway, was used to categorize 
proteins into families and subfamilies with shared 
functions. Some proteins were annotated manually based 
on literature searches and closely related homologues. 
The differentially expressed protein interaction network 
was generated with Pathway Studio version 5.0 software 
(Ariadne Genomis, Rockville, MD, USA) and Resnet 5 
database were used. Common downstream targets or 
upstream regulators of multiple proteins were identified 
by using this software, which facilitated the process of 
selecting key factors and potential mechanisms from the 
large number of differentially regulated proteins. 
RESULTS 
Comparative Serum Proteomic Analysis of 
Differentially Treated DD Samples 
The results of the experiment show a good repeatability. 
The authors have not found any keratin contamination in 
identification by mass spectrometry, so the results are 
reliable. 
To characterize the alterations in protein expression 
related to the treatment of DD, the authors performed 
2-DE analysis and proteomic analysis of serum protein 
extracts from different experimental groups (detailed in 
Materials and Methods). All the experiments were 
repeated in triplicates.  
The general information of proteins were analyzed, 
including the average protein dot numbers, matching dot 
numbers and matching scores. The average protein dot 
numbers of the 6 groups were 547 (normal control), 546 
(disease model control), 584 (Duxil), 587 (GEPRB 
group with low dose), 581 (GEPRB group with middle 
dose) and 576 (GEPRB group with high dose) 
respectively. Accordingly, comparing with normal 
control group, disease model group and GEPRB group 
with low dose, the matching numbers were 430,412 and 
434 respectively. The match scores were 79.6%, 75.6% 
and 75.8% respectively. The matching number of normal 
control group, disease model group and GEPRB group 
with middle dose were 430, 414 and 421 respectively. 
The match scores were 79.5%, 75.7% and 74.9% 
respectively under the control of normal control group. 
When compared with normal control group, disease 
model group and GEPRB group with high dose, the 
matching number were 444, 411 and 421 respectively. 
The match scores were 81.2%, 75.4% and 75.2% 
respectively under the control of normal control group. 
When compared with disease model group, Duxil group 
and GEPRB group with low dose, the matching number 
were 403, 404 and 402 respectively. The match scores 
were 71.6%, 72.2% and 73.1% respectively under the 
control of normal control group. When compared with 
disease model group, Duxil and GEPRB group with 
middle dose, the matching number were 397, 404 and 
402 respectively. The match scores were 71.1%, 72.7% 
and 73.1% respectively under the control of normal 
control group. When compared with disease model group, 
Duxil and GEPRB group with high dose, the matching 
number were 467, 456 and 438 respectively. The match 
scores were 76.7%, 76.9% and 72.6% respectively under 
the control of normal control group. Fifty-one 
differentially expressed proteins visualized with 
Coomassie brilliant blue staining were excised from the 
2-D gels and identified by MALDI-TOF MS/MS 
followed by database interpretation. Altogether, 13 non- 
redundant proteins were identified successfully, which 
indicates that GEPRB showed effects on the alteration of 
protein expression (Figure 1).  
Figure 1 showed the representative 2-D gel images for 
serum proteins extracted from different groups. The 
proteomic maps were compared with ImageMaster 2D 
Platinum software to identify the protein spot variations. 
Green colors above indicate the changed proteins that 
were successfully identified proteins.  
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The Representative Peptide Mass Fingerprint Maps 
of the Differentially Expressed Proteins Indentified in 
this Research 
The authors selected differentially expressed proteins in 
each individual protein as a representative peptide mass 
fingerprinting. From the results of Figure 2, the authors 
identified a number of their biochemical indicators of 
representative proteins by search through the database 
(Table 1 and 2, Figure 2 and 3 for more information).
Different matching number and match scores were 
generated by comparing with distinct combinations by 
MALDI-TOF MS/MS. Protein identification was 
performed on an Ultraflex III Proteomics Analyzer 
MALDI-TOF MS/MS (Ultraflex III, Bruker). The 
peptide mass spectrum was obtained in positive ion 
reflector mode. PMF combined MS spectra were 
searched against the NCBInr database using the 
MASCOT (Matrix Science, London, UK) Explorer 
software. Through Mascot search, there were 13 proteins 
identified altogether (Table1). 
Proteins from the serum were extracted and separated on 
a pH 4–7 NLIPG strip, followed by SDS-PAGE. After 
staining and image analysis, the spots were analyzed by 
MALDI-TOF MS/MS instrument. Results were from one 
representative experiment out of 3 (Table 1˅. 
Figure 1. 2-D gel maps of protein expression in different treatments. The green in images marked the specific location of 
difference protein points. High-dose groups, medium-dose group, low-dose group, model control group, normal control 
group, Duxil. 
Figure 2. The representative peptide mass fingerprint maps of the differentially expressed proteins indentified in this 
research. Peptide mass fingerprinting (PMF) of individual protein of differences protein in each group was selected as a 
representative. The protein was identified by Ultraflex III matrix auxiliary laser analytic ionization-time of flight mass 
spectrometer and positive ions reflectance mode of peptide mass spectrometry was acquired. Representative PMF of 
differentially expressed proteins in different groups was shown in Figure 2.
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Figure 3. Identification of Apolipoprotein E (apoE) protein corresponding to spot #403 of the 2-DE gel by PMF and 
database searches. A) MALDI-PMF of spot #403. B) MALDI-PST of spot #403. C) Sequence of apoE protein with 
indications of the detected peptides (red colour). The sequence coverage of apoE protein reached 71%. 
Functional Categories of Identified Proteins and 
Biologically Interactive Networking of Identified 
Proteins 
When proteins execute their functions in cells, they 
usually cooperate with others forming complicated 
signaling networks. To understand the biological rel- 
evance of the changes in protein expression during the 
medication treatment of DD, Biological Process and 
PANTHER classification systems were used to classify 
the 13 identified proteins into different functional groups 
as summarized in Figure 4A. The PANTHER 
classification system revealed that the proteins could be 
classified into 9 groups based on their functional 
properties (Figure 4B). 
From the result in Figure 4C, we can find that most of 
the authors’ identified proteins can be linked to apoE, C3 
and lots of transcriptional factors in the nucleus such as 
C/EBP proteins, pRb and POU2F1, et al. This indicated 
that apoE and C3 may be the potential drug targets of the 
authors’ drug. Above all, from the authors’ result, we can 
conclude that glycometabolism, lipid metabolism and 
immuno-system all participate in the regulation of this 
diseae, and this indicated that this disease is a 
multi-metabolic disorder and a immuno-dysfunctional 
disease. From the above bioinformatic analysis, it gives 
us a global understanding about the molecular 
mechanism of this disease and will provide useful 
informations for curing the disease (Figure 4, Table 2). 
Biologically Interactive Networking of Identified 
Proteins 
Bioinformatic analysis using Pathway Studio software 
enabled the characterization of biological association 
networks to relate to these differentially expressed 
proteins. The proteins networkable were linked by 
various relationships such as protein interactions, 
modifications and regulation of expression. These 
relationships were color coded, and the legends were 
provided next to the map. By this approach, we identified 
some functional groups alterable during the treatment of 
DD by GEPRB. These include insulin signaled pathway 
proteins, carbohydrate and lipid metabolic pathway 
proteins, etc. Several proteins remained unlinked because 
there was insufficient information in the database to link 
them to others in the network. Analyzing from the result 
in Figure 4, we could find that most of the authors’ 
identified proteins could be linked to apoE, C3 and lots 
of transcriptional factors in the nucleus such as C/EBP 
proteins, pRb and POU2F1 et al. This indicated that 
apoE and C3 could be the potential drug targets of 
GEPRB (Figure 4C).
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Figure 4. Bioinformatics analysis of the differentially expressed proteins. A) Pie chart representations of the distribution 
of identified proteins according to their molecular functions. Categorizations were based on information provided by the 
online resource PANTHER classification system. Some proteins were annotated manually based on literature searches 
and closely related homologues. B) Pathway mapping of altered protein expression using Pathway Studio. C) The 
identified proteins were imported into Pathway Assist, and an interaction map was generated. Shown proteins that either 
bound directly to another identified protein or to another identified protein via another protein. Each node represents 
either a protein entity or a control mechanism of the interaction. The legend of the interaction network was summarized. 
The biological network could be accessed via (http://life-health.jnu.edu.cn/pathway/pathway.html). 
   Table 2. Biological process of identified proteins
Protein Name Biological Process 
Alpha-1-macroglobulin Was able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This 
protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for 
different proteinases. Following cleavage in the bait region a thioester bond was hydrolyzed 
and mediates the covalent binding of the protein to the proteinase (By similarity). 
Ceruloplasmin Copper-containing protein 
Complement component 3 Derived from proteolytic degradation of complement C3, C3a 
anaphylatoxin was a mediator of local inflammatory process. It induces the contraction of 
smooth muscle, increases vascular permeability and causes histamine release from mast cells 
and basophilic leukocytes. 
Ig kappa chain Immunol Response, antibody production and secretion. 
Chain L Recognize The Main Immunogenic Region of The Human Muscle Acetylcholine Receptor 
Serum albumin Serum albumin, the main protein of plasma, had a good binding capacity for water, Ca (2+), 
Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function was the regulation of 
the colloidal osmotic pressure of blood. 
Notes: According to the function characteristics and biological significance of proteins, the biological process of part of differences  
protein which has been identified was analyzed in table 2. 
The Sub-cellular Localization and Transmembrane Region Prediction of the Sub-cellular Localization 
Protein
metabolism and
modification
BP00060
Homeostasis
BP00267
Blood circulation
and gas
exchange
BP00209
Signal
transduction
BP00102
Coenzyme and
prosthetic group
metabolism
BP00081
Lipid, fatty acid
and steroid
metabolism
BP00019
Sensory
perception
BP00182
Cell structure and
motility
BP00285
Immunity and
defense
BP00148
Transport
BP00141 TransporterMF00082
Protease
MF00153
Oxidoreductase
MF00123
Signaling
molecule
MF00016
Defense/immunity
protein (MF00173
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and Transmembrane Region
To fully understand the properties of the identified 
differentially expressed proteins, the authors analyzed 
the sub-cellular localization, trans-membrane region and 
signal peptides by Bioformatic method. The result was 
summarized in Table 3. Analyzing from the result, we 
could conclude that most of the identified proteins were 
secreted protein and belong to different protein families 
(for example apolipoprotein A1/A2/E, Lipocalin and 
serpin family et al).The sub-cellular localization of other 
proteins were difficult to predict because there was no 
efficient information about these identified proteins 
based on the authors’ Bioinformatic analysis. There were 
about 12 proteins have the transmembrane region from 
the authors' result, ten of them were plasma membrane 
proteins. 
Table 3. The sub-cellular localization and transmembrane region prediction
Gene Name Function Subcellular Location 
Alpha-1-macroglobulin 
When a proteinase cleaves the bait region, a conformational change was 
induced in the protein which traps the proteinase. The entrapped enzyme 
remaind active against low molecular weight substrates (activity against high 
molecular weight substrates was greatly reduced). Following cleavage in the 
bait region a thioester bond was hydrolyzed and mediated the covalent 
binding of the protein to the proteinase (By similarity). 
Secreted. 
alpha-2u globulin 
precursor 
Binds pheromones that were released from drying urine of males. These 
pheromones affected the sexual behavior of females.
Secreted. 
Apolipoprotein E 
Mediates the binding, internalization, and catabolism of lipoprotein particles. 
It could serve as a ligand for the LDL (apo B/E) receptor and for the specific 
apo-E receptor (chylomicron remnant) of hepatic tissues. 
Secreted. 
complement component 3
It induced the contraction of smooth muscle, increased vascular permeability 
and causes histamine release from mast cells and basophilic leukocytes. Secreted. 
F13b protein 
The F13B gene encodes the B subunit of factor XIII. This enzyme catalyzes 
the formation of crosslinking between fibrin molecules, thus stabilizing the 
fibrin clot. Factor XIII deficiency can result in a lifelong bleeding tendency, 
defective wound healing, and habitual abortion. 
Secreted 
(By similarity) 
Gelsolin 
Calcium-regulated, actin-modulating protein that binded to the plus (or 
barbed) ends of actin monomers or filaments, preventing monomer exchange 
(end-blocking or capping). It could promote the assembly of monomers into 
filaments (nucleation) as well as sever filaments already formed (By 
similarity). 
Cytoplasm, cytoskeleton 
(By similarity) 
Haptoglobin 
Haptoglobin combineed with free plasma hemoglobin, preventing loss of 
iron through the kidneys and protecting the kidneys from damage by 
hemoglobin, while making the hemoglobin accessible to degradative 
enzymes. 
Secreted. 
Major acute phase 
alpha-1 
Kininogens were plasma glycoproteins with a number of functions: 1) as 
precursor of the active peptide bradykinin they effected smooth muscle 
contraction, induction of hypotension and increase of vascular permeability. 
2) They played a role in blood coagulation by helping to position optimally 
prekallikrein and factor XI next to factor XII. 3) They were inhibitor of thiol 
proteases. 
Secreted, extracellular space. 
Retinol-binding protein Delivers retinol from the liver stored to the peripheral tissues. In plasma, the 
RBP-retinol complex interacts with transthyretin, this prevented its loss by 
filtration through the kidney glomeruli. 
Secreted. 
Serum albumin 
Its main function was the regulation of the colloidal osmotic pressure of 
blood. Major zinc transporter in plasma, typically binded about 80% of all 
plasma zinc. 
Secreted. 
Notes: In order to further understand the feature of differences protein, the authors also do sub-cellular localization and transmembrane 
analysis of the differences proteins which have been identified by bioinformatics method. 
DISCUSSION 
DD studied in this paper is a common clinical 
complication of diabetes. As the name implies, diabetes 
deafness is a kind of deafness caused by diabetes.8-10 In 
this paper, DD as the research object, in the proteomics 
level, more detailed study of the DD and DD in the 
molecular mechanism of GEPRB has been done. 
Traditional Chinese medicine (GEPRB) is popular in 
China and many East Asian countries. For about 5,000 
years, GEPRB has been proved to be efficient in 
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treatment for different types of disease. Previous study 
showed that GEPRB inhibited the diabetic-induced 
apoptosis of outer hair cells and ganglion spiral cells in 
the cochlear of rats, thus improving the auditory 
function.3 Proteins are the main components of the 
physiological metabolic pathways of cells. Proteomics, 
with the advantage of high-throughput screening of 
differentially expressed proteins, has been developed 
rapidly. However, recent studies on the pathogenesis of 
DD mainly focused on transcriptional level.3 Therefore, 
The authors applied proteomics analysis to screen 
potential targets for GEPRB. Differentially expressed 
proteins under different treatments are found to be 
associated with the development of disease. In this study, 
the authors used serum proteomic methods to clarify the 
therapeutic mechanism of GEPRB in DD and provide 
possible potential targets for DD treatment. 
The cure of diseases by TCM is a systematic process, 
because they always functions in targeting multiple 
factors,11,12 but the detail mechanism of TCM remains 
further deeply investigation.  
Since the functional aspects of TCM were multiple 
targets at multiple levels, high throughput methods were 
demanded for mechanistic investigation of TCM. 
Proteomics was a course developed in recent years which 
was credited for its high throughput in screening for 
differentially expressed proteins in global level.13 In the 
authors’ opinion, the introduction of proteomic analysis 
of the GEPRB may promote global understanding about 
the mechanism of curing diseases, and lots of new targets 
can be identified.14 The changed proteins under different 
treatments usually associated with the development of 
the disease and the pathways stimulated by the drug. In 
this manuscript, proteomics technology is applied to 
investigate the changes of serum protein levels in 
diabetic deafness (DD) rat model after treated by 
GEPRB for the first time. In addition to two-dimensional 
polyacrylamide gel electrophoresis (2-DE), serum 
protein profile was further performed using matrix-
assisted laser desorption/ionization mass spectrometry 
(MALDI-TOF MS/ MS). Analyzing from the results, the 
authors identified 13 differentially expressed proteins 
and analyzed the properties of these proteins in detail. To 
understand the biological functions of the changed 
proteins in systemization, Bioinformatic analysis was 
used in this manuscript. When proteins execute their 
functions in cells, they usually cooperated with others 
forming complicated signal networks. The differentially 
expressed protein interaction network was generated 
with Pathway Studio version 5.0 software and Resnet 5 
database were manipulated. The common downstream 
targets or upstream regulators of multiple proteins were 
identified by this software, which facilitated the process 
of selecting key factors and potential mechanisms from 
the large number of differentially regulated proteins. The 
Pathway Studio software also provides a desktop 
graphical user interface with capability to dynamically 
create and draw protein interaction networks and 
pathways, by linking the separated information from the 
reported literatures to the authors’ differentially 
expressed proteins. All interactions shown by Pathway 
Studio were connected to the original citation where the 
fact was recorded. 
Firstly, the authors analyzed the relationship of the 
identified proteins based on phosphorylation regulation, 
protein-protein interaction and direct regulation et al. 
Analyzing from the result (Figure 4C), we could find that 
most of the authors’ identified proteins could be linked to 
apoE, C3 and lots of transcriptional factors in the nucleus 
such as C/EBP proteins, pRb and POU2F1et al. This 
indicated that apoE and C3 maybe the potential drug 
targets of the authors’ drug.  
ApoE was an important apolipoprotein mainly 
synthesized in liver and macrophage.8 It was mainly 
described regarding to the effects on plasma lipoprotein 
metabolism and cholesterol homeostasis. The deletion of 
APOE could trigger metabolism handicap of triglyceride 
rich lipoproteins.9 The authors’ evidence indicated that 
besides its effects on regulation for plasma lipoprotein, 
APOE also acts as an immune modulator.15 In vitro study 
demonstrated that APOE could inhibit proliferation of 
lymphocyte, and it could also affect the T cell activation 
by influencing the expression of IL-2. APOE also 
modulated immune response and balance in mice.16
Although lots of works have been done about the 
function and regulation of APOE, none of the study has 
indicated the relationship between APOE and diabetes as 
well as its complications.  
C3 is a critical molecule in the complement immuno-
response. Up to date, there is little knowledge about the 
relationship between complement immuno-response and 
diabetes.17 But it is well known that type II diabetic is an 
autoimmune disease, lots of work should have been 
explored to shed light on this question. Finally, different 
pathways transduce the signals to the nucleus to regulate 
the activities of many different transcriptional factors, 
such as C/EBP-alpha, C/EBP-beta in the result.18 This 
indicated that the disease associated gene expression may 
be the final step resulting in the pathogenesis of this 
disease. This point of view has never been reported
before, further experiments were needed to prove this 
hypothesis.  
Of all the above, analyzing from the authors’ result, we 
could conclude that glycometabolism, lipid metabolism 
and immunosystem all participate the regulation of this 
disease, and this indicated that this disease was a multi- 
metabolic disorder and a immuno-dysfunctional disease. 
From the above Bioinformatic analysis, it gives us a 
global understanding about the molecular mechanism of 
this disease and will provide many potential drug targets 
and information for useful information for treating this 
disease. 
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In this paper, the authors identified 13 differentially 
expressed proteins by comparing different experimental 
groups (non-treatment control, animal model, positive 
drug control, GEPRB high dose, GEPRB middle dose 
and GEPRB low dose groups, and detailed in Materials 
and Methods). The authors then analyzed the identified 
proteins by bioinformatics methods to understand the 
protein-protein interaction networks and also mapping 
the proteins into their metabolic pathways. At last, the 
authors found that C3 and APOE were two high 
differentially expressed proteins. This indicated that 
APOE and C3 could be the potential drug targets of the 
authors’ drug (GEPRB). 
In a word, the authors used serum proteomic methods to 
clarify the therapeutic mechanism of GEPRB in DD and 
provide possible potential targets for DD treatment for 
the first time. This study not only provided many useful 
targets for understanding the GEPRB mechanism, but 
also gave us many identified factors for new drug 
designation. 
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